Georg Petzold

Georg Petzold

Auto-generated profile, based on publicly available information

Georg Petzold

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2016 in Nature
Verified
Journal Article
Closed access
GPGeorg Petzold
Georg Petzold
EFEric S. Fischer
Eric S. Fischer
NTNicolas H. Thomä
Nicolas H. Thomä

2 November 2018 in Science
Verified
Journal Article
Closed access
PDF file
QSQuinlan L. Sievers
Quinlan L. Sievers
GPGeorg Petzold
Georg Petzold
RBRichard D. Bunker
Richard D. Bunker
ARAline Renneville
Aline Renneville
MSMikołaj Słabicki
Mikołaj Słabicki
NTNicolas H. Thomä
Nicolas H. Thomä
Thalidomide-targeted degradation: Thalidomide and its analogs improve the survival of patients with multiple myeloma and other blood cancers. Previous work showed that the drugs bind to the E3 ubiquitin ligase Cereblon, which then targets for degradation two specific zinc finger (ZF) transcription factors with a role in cancer development. Sievers et al. found that more ZF proteins than anticipated are destabilized by thalidomide analogs. A proof-of-concept experiment revealed that chemical modifications of thalidomide can lead to selective degradation of specific ZF proteins. The detailed information provided by structural, biochemical, and computational analyses could guide the development of drugs that target ZF transcription factors implicated in human disease. Science , this issue p. eaat0572

25 April 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FWFlorian Weissmann
Florian Weissmann
GPGeorg Petzold
Georg Petzold
RVRyan VanderLinden
Ryan VanderLinden
PVPim J. Huis In 'T Veld
Pim J. Huis In 'T Veld
NBNicholas Brown
Nicholas Brown
JPJan-Michael Peters
Jan-Michael Peters
Significance: At the molecular level, most processes in living systems are mediated by multisubunit protein complexes. Recombinant forms of these complexes are essential for analyzing their structure and function. Multigene expression constructs greatly improve recombinant protein complex preparations, but the generation of such constructs can be a rate-limiting step. To overcome this limitation, we have adapted Gibson assembly reactions for the rapid, efficient, and fast generation of numerous expression constructs in parallel and used the resulting biGBac method for expression of different cell-cycle complexes, composed of up to 17 different subunits. The biGBac technique enables the analyses of large protein complexes by systematic mutagenesis approaches that were not feasible before.

30 March 2016 in Nature
Verified
Journal Article
Closed access
SCSimone Cavadini
Simone Cavadini
EFEric S. Fischer
Eric S. Fischer
RBRichard D. Bunker
Richard D. Bunker
APAlessandro Potenza
Alessandro Potenza
GLGondichatnahalli M. Lingaraju
Gondichatnahalli M. Lingaraju
NTNicolas H. Thomä
Nicolas H. Thomä

1 June 2016 in Cell
Verified
Journal Article
Closed access
NBNicholas Brown
Nicholas Brown
RVRyan VanderLinden
Ryan VanderLinden
EWEdmond R. Watson
Edmond R. Watson
FWFlorian Weissmann
Florian Weissmann
AOAlban Ordureau
Alban Ordureau
BSBrenda A. Schulman
Brenda A. Schulman

24 September 2012 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
KUKristina Uzunova
Kristina Uzunova
BDBilly T Dye
Billy T Dye
HSHannelore Schutz
Hannelore Schutz
RLRene Ladurner
Rene Ladurner
GPGeorg Petzold
Georg Petzold
JPJan-Michael Peters
Jan-Michael Peters
Activation of the anaphase-promoting complex/cyclosome (APC/C) depends on disassembly of the mitotic checkpoint complex (MCC), which has been proposed to require CDC20 autoubiquitylation. A new study involving reconstituted recombinant human APC/C supports the view that the APC15 subunit of APC/C localizes near the MCC binding site and mediates CDC20 autoubiquitylation, thereby promoting MCC disassembly. The anaphase-promoting complex/cyclosome (APC/C) bound to CDC20 (APC/CCDC20) initiates anaphase by ubiquitylating B-type cyclins and securin. During chromosome bi-orientation, CDC20 assembles with MAD2, BUBR1 and BUB3 into a mitotic checkpoint complex (MCC) that inhibits substrate recruitment to the APC/C. APC/C activation depends on MCC disassembly, which was proposed to require CDC20 autoubiquitylation. Here we characterize APC15, a human APC/C subunit related to yeast Mnd2. APC15 is located near APC/C's MCC binding site; it is required for APC/C-bound MCC (APC/CMCC)-dependent CDC20 autoubiquitylation and degradation and for timely anaphase initiation but is dispensable for substrate ubiquitylation by APC/CCDC20 and APC/CCDH1. Our results support the model wherein MCC is continuously assembled and disassembled to enable rapid activation of APC/CCDC20 and CDC20 autoubiquitylation promotes MCC disassembly. We propose that APC15 and Mnd2 negatively regulate APC/C coactivators and report generation of recombinant human APC/C.